Annotated Medicine and Device Lists

Salbutamol

Inhalation (aerosol) 100 mcg (as sulfate) per dose Injection 50 mcg (as sulfate)/mL in 5-mL ampoule Injection 0.5 mg/mL Metered dose inhaler (aerosol) 100 mcg (as sulfate) per dose Metered dose inhaler (aerosol) 0.1 mg/dose Metered dose inhaler (aerosol) Oral liquid 2 mg/5 mL Respirator solution for use in nebulizers 5 mg (as sulfate)/mL Respirator solution for use in nebulizers 5 mg/mL Respirator solution for use in nebulizers 0.5% Solution 10 mL Tablet 4 mg Tablet 2 mg

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	16.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	No observations
WHO Model List of Essential Medicines (2021)	25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	Others observations: Therapeutic alternatives: terbutaline
Colombia	11.2 Bronchodilators	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	16.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	No observations
WHO Model List of Essential Medicines (2021)	25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	Others observations: Therapeutic alternatives: terbutaline

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	11.2 Bronchodilators	No observations
Cuba	25.1.1 Agonistas Beta 2 selectivos	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	16.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	No observations
WHO Model List of Essential Medicines (2021)	25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	Others observations: Therapeutic alternatives: terbutaline
Peru	25.1 Anti-Asthmatics and Medications for Chronic Obstructive Pulmonary Disease	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Cuba	25.1.1 Agonistas Beta 2 selectivos	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	11.2 Bronchodilators	No observations
Cuba	25.1.1 Agonistas Beta 2 selectivos	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	16.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	No observations
WHO Model List of Essential Medicines (2021)	25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease	Others observations: Therapeutic alternatives: terbutaline
Peru	25.1 Anti-Asthmatics and Medications for Chronic Obstructive Pulmonary Disease	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Chile	Essential and Prioritized Medications	No observations
Cuba	25.1.1 Agonistas Beta 2 selectivos	No observations

This medicine is present in:

List	Section	Observation
Colombia	11.2 Bronchodilators	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Peru	22.2 Anti-Oxytocins	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	11.2 Bronchodilators	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations
Colombia	11.2 Bronchodilators	No observations
Cuba	25.1.1 Agonistas Beta 2 selectivos	No observations

Information Resources: Salbutamol

No information available